Cero Therapeutics Enters Material Definitive Agreement
Ticker: CEROW · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1870404
Sentiment: neutral
Topics: material-definitive-agreement, corporate-action, exhibits
TL;DR
CERO signed a big deal on 7/11/25, check the exhibits.
AI Summary
Cero Therapeutics Holdings, Inc. entered into a Material Definitive Agreement on July 11, 2025. The filing also includes financial statements and exhibits related to this agreement. Cero Therapeutics Holdings, Inc. was formerly known as Phoenix Biotech Acquisition Corp. until June 30, 2021.
Why It Matters
This filing indicates a significant new development for Cero Therapeutics, likely involving a partnership, acquisition, or other substantial business transaction that could impact its future operations and stock value.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce significant business and financial risks depending on the nature of the agreement.
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- July 11, 2025 (date) — Date of earliest event reported
- PHOENIX BIOTECH ACQUISITION CORP. (company) — Former company name
- June 30, 2021 (date) — Date of name change
FAQ
What is the nature of the Material Definitive Agreement entered into by Cero Therapeutics Holdings, Inc. on July 11, 2025?
The filing states that Cero Therapeutics Holdings, Inc. entered into a Material Definitive Agreement on July 11, 2025, but the specific details of the agreement are not provided in this summary.
What other information is included in this 8-K filing besides the Material Definitive Agreement?
This 8-K filing also includes Financial Statements and Exhibits related to the Material Definitive Agreement.
When did Cero Therapeutics Holdings, Inc. change its name from Phoenix Biotech Acquisition Corp.?
Cero Therapeutics Holdings, Inc. changed its name from Phoenix Biotech Acquisition Corp. on June 30, 2021.
What is the Standard Industrial Classification for Cero Therapeutics Holdings, Inc.?
The Standard Industrial Classification for Cero Therapeutics Holdings, Inc. is BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].
Where is Cero Therapeutics Holdings, Inc. located?
Cero Therapeutics Holdings, Inc. is located at 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA 94080.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).